Aptar Digital Health, part of AptarGroup, Inc. has entered into an enterprise agreement with Biogen Inc. to operate and develop digital health solutions for neurological and rare diseases. As part of the agreement, Biogen will transfer ownership of select digital health solutions to Aptar Digital Health (Aptar).
Through this collaboration, Aptar will provide a full range of capabilities including the product management, design, development and maintenance of software applications, secured cloud hosting, and customer and marketing support to Biogen.
Over the past years, Biogen has successfully launched several flagship digital health solutions which have supported hundreds of thousands of patients in over 15 countries. The first solutions to transition to an operation by Aptar in North America, Europe/UK, Asia-Pacific and Latin America are:
- Cleo™/Aby™: a digital care companion app to help people live with multiple sclerosis. It includes disease information, symptom-tracking, treatment reminders and tailored self-care programs on topics like fatigue and emotional management.
- Physio.me: a digital exercise companion that offers at-home, tailored exercises to patients with neuromuscular disorders who can measure and share their progress with their care team and can increase their likelihood to achieve their physical goals.
In addition to these solutions, Biogen and Aptar will further collaborate to potentially develop and bring to market new digital health solutions for the management of spinal muscular amyotrophy, Friedreich’s ataxia and lupus in selected countries.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from American Pharmaceutical Review – all delivered right to your inbox!
Sign up now!